Commercial Litigation Finance: How Big is This Thing?

By John Freund |

The following article is part of an ongoing column titled ‘Investor Insights.’ 

Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance. 

Executive Summary

MarketAustralia (AUS$)UK (£)USA (US$)
Implied Commitment CapacityAUS $1B£2BUS $10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B

The chart above summarizes the results of quantifying the size of the most mature markets for litigation finance.  If you were to attempt to perform the same analysis three years ago, I suspect you would find that the industry was less than half its current size.  Accordingly, it is a dynamic and growing market that should be on most investors’ radar screens if you are interested in non-correlated exposures.

Investor Insights

  • Growing, dynamic market
  • Diversification is critical to responsible investing; “tail risk” can be significant
  • Relatively few managers with long track records
  • New investors should focus on the small subset of experienced fund managers

Approach and Limitation of Sizing

I am often asked about the size of the commercial litigation finance market by individual and institutional investors alike, whether relative to the US market or other large global markets. I often hesitate to answer the question as the answer is dependent on an element of transparency not currently inherent in the industry itself.  Nevertheless, I think it is important for all stakeholders to understand the size of an industry, so investors can determine whether it has the scale and growth attributes necessary to justify a long-term approach to investing in the sector.

However, before I describe the approaches taken, I think it is important to recognize the limitations of attempting to size the industry, as past estimates have varied wildly.

Limitation #1: Dedicated Funds vs. Opaque Capital Pools vs. Non-Organized Capital Pools

While there are many dedicated litigation funders (“Funders”) servicing the global marketplace, both private and publicly-traded, they only represent a portion of the available financing for the industry (especially in the US). Even the Funders that service the market are relatively private about the amount of capital they have available and the amount of capital they deploy annually (not to mention committed capital vs. drawn capital).  On the odd occasion, you will have a funder trumpet their latest close size, but it is often just a headline number and you are left wondering exactly what it means as it could be inclusive of co-invest capacity, side cars, discretionary separately managed accounts, etc.

Then there are the Opaque Capital Pools.  These are the hedge funds, the multi-strategy funds with a sliver of their fund dedicated to litigation finance, merchant banks, credit funds, etc.  Even PIMCO, the world’s largest bond fund, has allocated capital to one of the UK funders (a tiny allocation for PIMCO, but perhaps the ‘thin edge of the wedge,’ if they achieve success).  The problem from a data perspective is that many of these funding sources don’t disclose how much of their capital has been allocated to litigation finance, as they don’t necessarily want the world, or their competitors, to know where they are investing.

Finally, there are a host of other financiers in the marketplace, which I will refer to as Disorganized Capital Pools.  These are the lawyers, law firms, High Net Worth (HNW) and Ultra HNW (UHNW) individual investors, family offices and the like that have decided they want exposure to single case risks or portfolios thereof.  Investors who have not dedicated a lot of time and attention to the asset class are probably best served by investing in a series of funds, as opposed to going direct with one manager or a series of individual cases.

Often times, the second and third categories are what I call flexible pools of capital, meaning that if they achieve success in investing they will allocate more capital, and if they don’t have a positive experience they will retreat and ‘run-off’ their remaining investments, and “chalk that one up to experience”.   The Opaque Capital Pools and Disorganized Capital Pools are what I refer to as “Non-Fund Investors”.  Accordingly, due to the flexibility and private nature of the Opaque and Disorganized Capital Pools, it is difficult to determine the exact amount of capital they represent at any given point in time.

Limitation #2: Financing Fees vs. Financing Out of Pocket

There is a distinction in the industry between financing legal fees (which is not always possible in all jurisdictions) and financing out-of-pocket expenses (court costs, discovery costs, expert reports, etc.).  There is also a third bucket where financiers will provide “working capital” as part of their litigation finance commitment. Funds which provide working capital are grounded in a belief by the Funder that the piece of litigation has value, and if the value exceeds the various costs necessary to pursue the case, then they are comfortable providing any excess capital to the business for working capital purposes.  The other aspect to working capital is that the litigation funder does not want to find itself in the middle of litigation with an insolvent enterprise where the management team is no longer focused on the litigation prize, and so they argue it is in their best interest to keep the company solvent while the litigation is being pursued.  Arguably, working capital loans belong in the world of specialty finance, not litigation finance, but in this case the underlying security is the outcome of the litigation.

The reason I draw the first distinction is because it could be argued that a large segment of litigation finance is already being provided through contingent fee arrangements, which have been in existence for decades in the US, but have been the sole purview of lawyers.  Should these contingent fees count towards industry sizing?  I think a logical argument can be made that they should be included, as these are funds that could or would otherwise be provided by a third-party litigation funder, but then again, they will never be funded by Funders. Some people believe that law firms are taking the best cases for themselves and the litigation funding industry is fighting for the cast-offs (termed ‘adverse selection risk’).  I don’t necessarily subscribe to this theory, as the high success rates in the Litigation Finance industry support the notion that good cases are being undertaken by third party funders.

Interestingly, one of the world’s largest law firms, Kirkland & Ellis, recently announced that they are going to double down on their contingent fee arrangements through the establishment of a plaintiff side litigation group, which was previously the sole purview of scrappy plaintiff side lawyers (many of whom have achieved tremendous financial success in doing so). Perhaps the grass really is greener…

For the purpose of this article, I have assumed that contingent fees are not included in the industry sizing exercise.

Limitation #3: It’s Getting Global

A few years ago, the various funders were entrenched in their local jurisdictions and happy to toil away in their own back yards. Then something interesting happened.  It got global, fast!  Over the last 3-5 years, the industry saw litigation funders move outside of their home base, and do so in a significant way.  UK funders moved into the US, Australian funders moved into the US and UK, UK funders moved into Australia, and more recently, some funders figured my host country, Canada, was also an interesting opportunity.  Is this a reflection of their local markets being saturated, or is this a global ‘land grab’? I point this out because when you analyze pools of capital by litigation funders, you cannot solely look at where that funder is domiciled and conclude their capital is solely dedicated to their home country.  Some funders, like IMF Bentham, have set up dedicated pools to service the US and other pools to service Rest of World (i.e. ex-US).  Other funders do not have dedicated pools, but look for the best risk-adjusted opportunities around the globe, or in specific markets in which they are comfortable investing (typically other English common law or common law derived markets, but not necessarily so).  I say this because the available data forces one to look at global litigation funding sizing, as it is difficult to know where the funder will deploy its capital.  This doesn’t even consider foreign exchange rate fluctuations and their effect on industry sizing – the Brexit impact on the GBP would have had a significant impact on the USD equivalent alone.

Limitation #4: Cultural Differences and Punitive Damages

There is no arguing that the US is a much more permissive culture in terms of utilizing litigation to settle differences – ‘nothin’ like a good gun fight to settle a dispute’, one might say.  This means that while the size of the litigation industry is much larger, one could argue that you have to parse out the less meritorious claims to find the jewels that litigation finance would support – their money is not frivolous, hence the cases they fund are also not frivolous. Accordingly, when you look at the size of the entire industry, you must assign a lower litigation funding applicability rate in the US because of the aggressive nature of the claim environment (i.e. while the US legal market is much larger because the culture is more permissive, there are a smaller percentage of claims that attract litigation finance).

The second and more important issue, is the relative extent of punitive damages in the American civil justice system vs other civil justice systems.  There is no doubt – and it has been well documented through empirical evidence – that awards are larger in the US.  Accordingly, this would suggest that comparing data from other jurisdictions and applying that to try and size the US market, or any other market for that matter, is somewhat limiting.

In addition, each market has its own nuances and peculiarities, and so it is very difficult to compare different jurisdictions and draw solid conclusions.  All of the aforementioned would suggest the industry is difficult to size with any degree of accuracy.  I think there is some truth to that supposition.

Limitation #5 – What is included in “Commercial”?

While the commercial litigation finance market is generally defined to include financing of litigation involving two corporate entities, the funders involved in the space have expanded the definition to include, amongst other things, Investor-State, product class action and insolvency cases where there is typically not another commercial entity on the other side of the dispute, but rather a sovereign, a set of consumers or an individual (director or shareholder), respectively.  Accordingly, the commercial litigation finance funders have expanded the definition of what is included in the market by including large, complex cases involving non-commercial entities.  Nevertheless, these cases are typically financed by commercial litigation finance funders and should be captured in the size estimates.

So, with all of the limitations above, I have tried to approach industry sizing using a pair of different approaches: micro and macro.

Macro Perspective: 

When looking at it from a macro perspective, I like to focus on one of the more mature markets for litigation finance and draw inferences – that market being Australia.

Australia is a common law market; it has been utilizing litigation finance for close to two decades, and therefore is one of the more mature markets, which suggests market penetration for Litigation Finance is relatively high.  The one limitation of using Australia as a benchmark is that the jurisdiction generally does not allow contingent fees, so arguably, litigation finance levels are higher because lawyers are not able to put their fees at risk, hence their fees are financed by Funders.  I also believe Australia has fewer Non-Funder investors than the United States, and so we can likely draw better conclusions about the size of their market by looking at the active funders there.

The following chart attempts to put the relative markets into perspective.

CountryContingent FeesAdverse CostsLitigation CultureLegal MarketFunding Type
USYesNoPermissive$437B USLegal fees, working capital & disbursements
UKYesYesModerate£29B GBPLegal fees & disbursements
AustraliaNoYesModerate$21B AUDLegal Fees, disbursements & indemnities

So, if one considers the Dedicated Funds in Australia, and tries to estimate the amount of capital they have dedicated to the local industry and compare that to the overall size of the litigation market (a number that is fairly well tracked), we can see that the Australian market is approximately AUS$200-300MM in annual commitments, and has commitment capacity of about 2-3 times that, or $500-750MM (using the mid-point).  This would suggest that litigation finance – in terms of annual commitments – represents about 1 to 1.5% of their $21B legal market (where the “legal market” is the market for all legal services, not just those dedicated to litigation).

Applying the same methodology to the UK market, and adjusting for the fact that contingent fees are more prevalent in the UK, one could argue that the UK market, being younger than the Australian market, should be less penetrated, with less capital being required due to contingent fees.  Perhaps the litigation finance market is closer to 1% of the legal market, or approximately £290MM and commitment capacity of 2-3 times that amount of £600-900MM.

Extending this logic to the US market, and allowing for a strong punitive damage system, strong contingent fee usage and a low relative penetration rate, we can surmise that the market is similarly close to 1% of the size of its legal market, or $4B in annual commitments with commitment capacity of 2-3 times that or $8-12B.

MarketAustralia (AUS$)UK (£)USA (US$)
Commitment CapacityAUS $500-750MM£600-900MMUS $8-12B
Annual CommitmentsAUS $ 2-300MM£250-350MMUS $3-4B

Micro Perspective:

The other approach to sizing the market is to build up the annual commitments and the commitment capacity on an investor-by-investor basis.  Westfleet Advisors has recently published a “Buyer’s Guide” to estimate the size of the US market using this approach, and their results seem to correlate with the approach I have used below.  The difference in results between our two approaches results from the size of the non-fund sources of capital, and my approach is admittedly a best guess estimate.  Nevertheless, I have used the following assumptions to try and triangulate the market sizes.  I took my knowledge of the various funders’ commitment capacity in each of the jurisdictions to determine the total commitment capacity of the market, and then I interpolated the size of the total market by estimating what percent of funding is represented by these Dedicated Funds.

MarketAustralia (AUS$)UK (£)USA (US$)
Fund Commitment CapacityAUS $1B£1.6BUS $5B
% of Market represented by Funders100%80%50%
Implied Commitment CapacityAUS $1B£2BUS $ 10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B
1 Annual commitments determined by dividing the Commitment Capacity by 3 (typical fund investment period, assuming extensions)

Conclusion

The two approaches seem to triangulate fairly well, and are buttressed by the micro analysis performed by WestFleet in the US market.  Accordingly, I think the two approaches provide a high-level view of the amount of capital available and annual commitments for the various jurisdictions.  While I would not rely on the exact figures, I believe the numbers are directionally correct, and provide investors with an order of magnitude assessment of the current market as to whether this market provides sufficient scale to justify a long-term exposure to the asset class, or whether investors should consider it a more opportunistic investment within one of their niche strategies or pools of capital.

While the industry is presently not sizable enough to attract many large pension plans and sovereign wealth funds that typically invest no less than $100’s of million at a time, it is quickly achieving a level of scale that has become attractive to some larger investors. By example, a large sovereign wealth fund has made a US$667MM commitment to Burford’s 2019 Private Partnership through a separately managed account.  The remaining external capital, $300 million, was provided by a series of small and medium-sized investors rumoured to include family offices, foundations, endowments and the like.  Whereas this scale of investor would not have invested in the asset class even three years ago, it appears the more aggressive of these investors have decided this is an asset class that merits serious consideration and investment, and I expect more to follow.

Investor Insight: For investors interested in investing in one of the truly non-correlated asset classes, they would be best to spend the time to analyze the various managers in the sector, of which there are relatively few on a global basis that I would consider “institutional” in nature.  They would also be well served to focus on those few managers with  a track record that includes fully realized funds, of which there are even fewer, or be prepared to spend the time and resources to assess the unrealized portion of those managers’ portfolios as ‘tail risk’ in this industry can be significant depending on the concentration of the portfolio.  As always, diversification is a key success factor to investing in this asset class as the idiosyncratic risk of cases and the binary nature of trial/arbitral awards make it particularly well suited for the application of portfolio theory.

Edward Truant is the founder of Slingshot Capital Inc. and an investor in the consumer and commercial litigation finance industry.

Commercial

View All

The Dangers of Retrospective Legislation in Litigation Funding

By John Freund |

The debate around whether the Litigation Funding Agreements (Enforceability) Bill should be retrospective is a complex one, with valid arguments on both sides. A recent op-ed makes the case that retrospectivity poses significant dangers and unfairness.

Writing in LegalFutures, Jeremy Marshall, Chief Investment Officer of Winward UK, argues that the core issue is whether it is unfair to allow litigation funders to rely on contractual agreements that were freely entered into by both parties, even if those agreements were based on a mistake of law.

Marshall claims that the common law right to recover money paid under a mistake only applies when the mistake led to one party receiving an unintended benefit. In the case of litigation funding, the only benefit that has accrued is the one that was explicitly drafted into the contract. Allowing retrospectivity would open the door to satellite litigation and unreal counterfactuals, according to Marshall.

Claimants who have already received funding and won their cases are now arguing for the "right" to renegotiate and keep all the proceeds for themselves. But what about the funders' arguments that cases may have gone on longer or become more expensive than intended? Fairness demands that both sides' positions be considered.

Marshall insists that the true drawback in retrospectivity is the inherent danger of prejudicing one party to the exclusion of the other, or conferring an unexpected benefit to one party at the expense of the other. Ironically, this is precisely what those challenging the bill are attempting to do. So while the debate is a complex one, one can make a compelling case that retrospectivity in litigation funding poses significant dangers and unfairness.

ReplyForward

The CJC’s Review of Litigation Funding Will Have Far-Reaching Effects

By John Freund |

The following is a contributed piece by Tom Webster, Chief Commercial Officer at Sentry Funding.

Reform is on its way for the UK’s litigation funding sector, with the Civil Justice Council firing the starting gun on its review of litigation funding on 23 April.

The advisory body set out the terms of reference for its review, commissioned by lord chancellor Alex Chalk, and revealed the members of its core working group.

The review is working to an ambitious timetable with the aim of publishing an interim report by this summer, and a full report by summer 2025. It will be based on the CJC’s function of making civil justice ‘more accessible, fair and efficient’.

The CJC said it will set out ‘clear recommendations’ for reform in some areas. This includes consideration of a number of issues that could prove very significant for funders and clients. These include:

  • Whether the sector should be regulated, and if so, how and by whom;
  • Whether funders’ returns should be subject to a cap; and if so, to what extent;
  • The relationship between third party funding and litigation costs;
  • The court’s role in controlling the conduct of funded litigation, including the protection of claimants and ‘the interaction between pre-action and post-commencement funding of disputes’;
  • Duties relating to the provision of funding, including potential conflicts of interest between funders, lawyers and clients;
  • Whether funding encourages ‘specific litigation behaviour’ such as collective action.

The review’s core working group will be co-chaired by CJC members Mr Justice Simon Picken, a Commercial Court judge, and barrister Dr John Sorabji. The four other members are:

  • High Court judge Mrs Justice Sara Cockerill, who was judge in charge of the commercial court 2020 – 2022, and who is currently involved in a project on third party funding for the European Law Institute;
  • Academic and former City lawyer Prof Chris Hodges, chair of independent body the Regulatory Horizons Council which was set up to ensure that UK regulation keeps pace with innovation;
  • Lucy Castledine, Director of Consumer Investments at the Financial Conduct Authority; and
  • Nick Bacon KC, a prominent barrister and funding expert who acts for both claimants and defendants

The CJC had said that it may also bring in a consumer representative, as well as a solicitor experienced in group litigation.

In a sign that the review seeks to be informed by a wide range of views, the CJC has also extended an invitation for experts to join a broader consultation group, which will directly inform the work of the review and provide a larger forum for expert discussion. Meanwhile the advisory body has said there will also be further chance ‘for all to engage formally with this review’ later this year.

Given the broad remit of the review and significant impact that its recommendations may have on the litigation funding industry, litigation funders, lawyers and clients would be well advised to make the most of these opportunities to contribute to the review.

Read More

Balancing Risk and Reward in Litigation Finance: Lessons from High-Profile Case

By John Freund |

The following is a contributed piece by Jeff Manley, Chief Operating Officer of Armadillo Litigation Funding.

The allure of substantial returns from mass tort litigation has historically tempted law firms and their third-party financiers to commit resources to speculative cases. While investing strongly in speculative torts certainly has its time and place, prevailing trends highlight the necessity of certain risk management practices. The unpredictable outcomes of high-profile cases, like the Camp LeJeune water contamination lawsuits, accentuate the imperative for a discerning approach to case selection and the strategic diversification of portfolios.

Balancing Opportunity and Prudence in Speculative Torts

Early-stage speculative torts like the Zantac litigation represent a blend of potential and caution. (In re Zantac (Ranitidine) Products Liability Litigation, 2021). Initially, Zantac cases drew significant attention from law firms with projections of substantial compensation figures. However, the legal complexities and subsequent valuation adjustments highlighted the disparity between initial projections and actual compensation figures realized, reinforcing the need for meticulous risk assessment in speculative torts. While similar cases have captivated law firms and financiers with their substantial projections, they also underscore the importance of an exhaustive risk assessment—demonstrating how initial excitement must be tempered with diligent legal analysis and realistic valuation adjustments.

Navigating the Complex Terrain of Camp Lejeune Litigation

The Camp Lejeune water contamination lawsuits represent promising ventures for financiers and mass tort firms to affirm their moral duty by advocating for those who served our country. However, these cases also carry lessons on the pitfalls of overzealous investment without careful scrutiny. The drawn-out nature of the litigation serves as a reminder that while the pursuit of justice is noble, it must be balanced with sound risk management to ensure long term firm stability.

Endurance in Talc Litigation: A Testament to Long-Term Vision

The protracted legal battles surrounding talcum powder’s health risks underscore the necessity for long-term strategic planning in mass tort litigation. Firms must factor in the operational demands and the financial foresight to manage compounded interest on borrowed capital over extensive periods. Simultaneously, it’s critical to sustain investment in new torts, ensuring a balanced portfolio that accommodates both ongoing cases and emerging opportunities. This balanced approach underpins the stamina needed to endure through a decade-long commitment, as exemplified by the talc litigation.

Understanding Returns in the 3M Earplug Litigation

The 3M earplug litigation concluded within a standard timeframe, yet the distribution of settlements spans several years, offering more modest financial returns than many anticipated. This outcome serves as a pragmatic reminder of the nuanced nature of mass tort settlements, where significant payouts are not always immediate or as substantial as predicted. Nonetheless, this reinforces the value of prudent risk management strategies that account for longer payout terms, ensuring a stable financial forecast and the firm's resilience in the face of lower-than-expected returns.

Strategic Portfolio Diversification

Given these varied experiences, it is imperative that law firm owners and financial backers craft a robust case portfolio strategy. By balancing the mix of cases from speculative to those with a more established settlement trajectory, firms can better manage risk and ensure operational stability. Strategic diversification is not just wise—it’s a vital tactic to maintain resilience in the evolving landscape of the mass tort industry.

The Value of Expert Financial Partnerships

Choosing a reputable and experienced litigation finance partner is essential for law firms aiming to effectively balance their case portfolios. A seasoned funding partner provides invaluable guidance in evaluating potential cases, assessing financial risks, and optimizing investment strategies. Their expertise in navigating the nuanced terrain of litigation finance is a critical asset.

Adopting a balanced portfolio strategy—carefully curated to include a variety of torts at different development stages—provides a more stable foundation than pursuing an "all-in" strategy on a single high-potential tort. This method not only reduces dependency on the success of any single case but also positions the firm more favorably in the eyes of prudent lenders.

Recent high-profile cases in the mass tort arena, like those mentioned above, serve as potent reminders of the inherent uncertainties in litigation finance. For law firm owners and their financial backers, the path forward demands a nuanced view of risk, underscored by strategic portfolio diversification and the cultivation of partnerships with experienced financing entities. By adopting these principles, stakeholders can safeguard their investments against the capricious nature of mass litigation, securing a resilient and prosperous future in the challenging yet rewarding domain of legal finance.

Read More